AI Science Tracker
EN

The First Affiliated Hospital of China Medical University

1 discovery from 2020

Discoveries

Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling.

Source check: Source checked. Not independent scientific confirmation.

Finding: Supervised/unsupervised ML on six genomic datasets and 26 stem-cell gene sets yielded three bladder-cancer stem-enrichment subtypes, with cross-platform stability and distinct prognosis/immune/therapy associations. Predicted treatment sensitivities remain computational, not clinical response evidence. Organization is unavailable in the deposited bibliographic metadata.

Technology: Supervised and unsupervised machine-learning subtype models

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Supervised/unsupervised ML on six genomic datasets and 26 stem-cell gene sets yielded three bladder-cancer stem-enrichment subtypes, with cross-platform stability and distinct prognosis/immune/therapy associations. Predicted treatment sensitivities remain computational, not clinical response evidence.
Test and result
Supervised/unsupervised ML on six genomic datasets and 26 stem-cell gene sets yielded three bladder-cancer stem-enrichment subtypes, with cross-platform stability and distinct prognosis/immune/therapy associations. Predicted treatment sensitivities remain computational, not clinical response evidence.
Limitation / still unknown
Predicted treatment sensitivities remain computational, not clinical response evidence.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7594303/

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.